New Breast Reconstruction Procedure Demonstrates Long Term Success in European Trial; Data Reported From Cytori's RESTORE-2 Study of the Celution(R) System
02 mars 2011 06h00 HE
|
Cytori Therapeutics, Inc.
ZUG, SWITZERLAND and SAN DIEGO, CA--(Marketwire - March 2, 2011) - Results from a European breast reconstruction trial using a new minimally invasive procedure to repair lumpectomy defects resulted in...
Cytori to Webcast Corporate Presentation at CitiBank Global Healthcare Conference on March 2 Followed by Fourth Quarter Earnings on March 10
28 févr. 2011 07h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - February 28, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present and provide a webcast of their corporate presentation at the CitiBank 2011 Global Healthcare...
Cytori Granted Foundational Japanese Patent for Its Celution(R) System Technology; Covers Automated Methods for Processing Stem and Regenerative Cells From Adipose Tissue
25 févr. 2011 08h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - February 25, 2011) - Cytori Therapeutics (NASDAQ: CYTX) has been issued Patent No. 4653952 (the '952 patent) from the Japan Patent Office covering devices for extracting...
Sound Surgical Technologies to Promote Cytori's PureGraft(TM) System -- the Latest Innovation in Fat Grafting
31 janv. 2011 07h30 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 31, 2011) - Sound Surgical Technologies LLC (SST) and Cytori Therapeutics (NASDAQ: CYTX) have signed a sales agreement through which Cytori's fat grafting...
Fat Grafting Safety Review Published; Clinical Experience Shows No Increased Risk of Cancer in Fat Grafting Patients
24 janv. 2011 07h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 24, 2011) - Published clinical experience in over 2,000 patients who received autologous fat grafts showed no evidence of increased risk of development, metastasis...
Adipose-Derived Regenerative Cell (ADRC) Therapy Associated With Reduction in Arrhythmia in Acute Heart Attack Patients; Post-Hoc Data From Cytori's APOLLO Study Reported at the 6th International Conference on Cell Therapy for Cardiovascular Disease
20 janv. 2011 19h45 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 20, 2011) - Cytori Therapeutics (NASDAQ: CYTX) announced this afternoon the presentation of data demonstrating a statistically significant reduction in...
Beginn der Cytori-Pivotalstudie zu Stammzellen und regenerativen Zellen zur Behandlung von Herzinfarkt in Europa genehmigt; Aufnahme von Studienteilnehmern am ersten ADVANCE-Studienzentrum in den Niederlanden steht bevor
20 janv. 2011 07h30 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 20, 2011) - Cytori (NASDAQ: CYTX) wurde die Genehmigung
in den Niederlanden zur Einleitung einer europäischen Pivotalstudie mit der
Bezeichnung ADVANCE...
Cytori krijgt goedkeuring voor een registratieonderzoek naar de behandeling van hartaanvallen met stamcellen en regeneratieve cellen; eerste ADVANCE onderzoekscentrum begint rekrutering in Nederland
20 janv. 2011 07h30 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 20, 2011) - Cytori (NASDAQ: CYTX) heeft goedkeuring
verkregen van Nederland om te starten met een Europees
registratieonderzoek, ADVANCE genoemd, voor het...
Cytori Approved to Initiate Pivotal Stem & Regenerative Cell Heart Attack Trial in Europe; First ADVANCE Trial Site to Begin Enrollment in the Netherlands
20 janv. 2011 07h30 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 20, 2011) - Cytori (NASDAQ: CYTX) received approval from The Netherlands to initiate a pivotal European trial, named ADVANCE, to investigate adipose-derived...
Cytori Announces January Conference Schedule
07 janv. 2011 07h00 HE
|
Cytori Therapeutics, Inc.
SAN DIEGO, CA--(Marketwire - January 7, 2011) - Cytori Therapeutics (NASDAQ: CYTX) today announced their conference schedule for the month of January. Upcoming presentations include:
...